Funding for this research was provided by:
Canadian Institutes of Health Research (PPP-141710)
Leading Edge Endowment Fund
Text and Data Mining valid from 2020-03-19
Received: 30 December 2019
Accepted: 18 February 2020
First Online: 19 March 2020
: All applicable institutional and/or national guidelines for the care and use of animals were followed, and the study protocol was approved by the institutional Research Ethics Board.
: Not applicable.
: Drs. Jinhe Pan, David M. Perrin, Kuo-Shyan Lin, and François Bénard are co-inventors of a patent that covers [<sup>18</sup>F]AmBF<sub>3</sub>-TATE and the BF<sub>3</sub> platform, and are shareholders of Alpha-9 Theranostics, which holds a license to the technology.